ArticleGynecologic oncology2020

The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma.

Nicoletta Colombo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.